People on GLP-1 agonist drugs such as Mounjaro, Ozempic and Wegovy have been reporting hair loss

The analysis found GLP-1 drugs slashed the risk of alcohol-related hospital admission by 26% compared with other diabetes medicines

Absolute risk of alopecia was low, however